At Nagi Bioscience, we develop cutting-edge biological testing solutions enabling scientists to generate the insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way.
Our pioneering Organism-on-Chip platform, SydLab™ One, seamlessly integrates into existing lab environments, enabling scientists to enhance efficiency, accuracy, and reproducibility like never before.
By combining this innovative technology with our team’s expertise, we deliver customer-focused solutions that empower scientists to advance research and drive scientific thinking forward.
#inwormwetrust
Company Details
- Employees
- 49
- Founded
- -
- Address
- Rue Des Jordils 1a, Epfl Innovation Park
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://nagibio.ch/
- Keywords
- Microfluidic technology, Drug Screening, Pre-clinical studies, Lab Automation Technology, Safety and Efficacy, Toxicology, AI, C. elegans, 3Rs, Biomedical Research, Neurodegeneration studies, Aging research, Innovation.
- HQ
- Saint-Sulpice, Vaud
Nagi Bioscience Questions
Nagi Bioscience's website is http://nagibio.ch/
Nagi Bioscience's LinkedIn profile is https://www.linkedin.com/company/nagibioscience
Nagi Bioscience has
49 employees.
View email and phone details for 49
employees at Nagi Bioscience.
Nagi Bioscience's industry is
Biotechnology Research
Nagi Bioscience's top competitors are
Adularia,
Inkvivo Technologies Ag,
Tandem Therapeutics,
Haya Therapeutics,
Synendos Therapeutics Ag,
Muvon Therapeutics Ag,
Cellestia Biotech,
Limula,
Araris Biotech Ag,
Adaptyv.
Nagi Bioscience's categories are Biotechnology Research
Nagi Bioscience's founding year is 2019
